Proliferation of K1 and BCPAP cells was evaluated using the MTT assay (Sigma-Aldrich; Merck KGaA). Cells were plated in 96-well microtiter plates at a density of 3×103 cells/well in a volume of 180 µl DMEM with FBS. PLX4032 with or without gefitinib was diluted in media containing 1% DMSO at 10X the final assay concentrations (PLX4032: 0.01, 0.03, 0.1, 0.3, 1 and 3 µM; gefitinib: 0.125 µM). After 24 h of culture, 20 µl each drug dilution was added in triplicate to separate wells. Cells were assayed for proliferation at 24, 48, 72, 96 and 120-h time points. The percentage of inhibition was calculated using the following formula: 100-(mean absorbance of experimental wells/mean absorbance of control wells) ×100. The half maximal inhibitory concentration (IC50) values were determined by calculating the regression of plots produced from the logarithms of concentration vs. percentage inhibition, using XLfit software (version 4.2; ID Business Solutions Ltd., Guildford, UK).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.